PDA

View Full Version : “…evaluating palbociclib (CDK4/6) treatment outcome …”


Nguyen
09-17-2020, 04:43 PM
https://www.biospace.com/article/releases/clinical-cancer-research-publishes-results-supporting-divitum-as-a-technology-for-early-evaluation-of-metastatic-breast-cancer-treatment/

https://clincancerres.aacrjournals.org/content/26/9/2131.abstract

https://www.nature.com/articles/s41598-020-61416-1

I need to be more rigorous in monitoring/reading research, these articles were published in Jannuary/2020. I believe they are filing for FDA approval of Divitum.

Nguyen